Market Research Industry Reports

Histogenics Corp (HSGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Histogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders. The companys product include neocart, an tissue implant produced using a patients own cartilage cells which are harvested from non-weight-bearing cartilage surface of the patients femur. Its products is used to repair knee cartilage damage. Histogenics offers regenerative medicine platform that combines bioadhesives, cell processing, scaffolding, tissue engineering and growth factors to provide solutions for cartilage injuries associated with bone loss and arthritis. It also provides a platform for tissue repair solutions. Histogenics is headquartered in Waltham, Massachusetts, the US.

Histogenics Corp (HSGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Histogenics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Histogenics Corp, Medical Devices Deals, 2012 to YTD 2018 9
Histogenics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Histogenics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Histogenicsc Amends Licensing Agreement with Purpose for NeoCart 11
Equity Offering 12
Histogenics Raises USD6.3 Million in Public Offering of Shares 12
Histogenics Files Registration Statement for Public Offering of Shares to Raise USD50 Million 14
Histogenics Corp - Key Competitors 15
Histogenics Corp - Key Employees 16
Histogenics Corp - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Mar 15, 2018: Histogenics Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2017 18
Aug 10, 2017: Histogenics Announces Second Quarter 2017 Financial and Operating Results 21
May 11, 2017: Histogenics Announces First Quarter 2017 Financial and Operating Results 23
Mar 16, 2017: Histogenics Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2016 24
Corporate Communications 26
Oct 12, 2017: Histogenics Promotes Stephen Kennedy to Executive Vice President & Chief Operating Officer 26
Sep 18, 2017: Histogenics Announces Resignation of CMO 27
Jun 05, 2017: Histogenics Announces the Appointment of Donald Haut, Ph.D. as Chief Business Officer 28
Other Significant Developments 29
Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List Of Tables

List of Tables
Histogenics Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Histogenics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Histogenics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Histogenics Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Histogenics Corp, Medical Devices Deals, 2012 to YTD 2018 9
Histogenics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Histogenicsc Amends Licensing Agreement with Purpose for NeoCart 11
Histogenics Raises USD6.3 Million in Public Offering of Shares 12
Histogenics Files Registration Statement for Public Offering of Shares to Raise USD50 Million 14
Histogenics Corp, Key Competitors 15
Histogenics Corp, Key Employees 16
Histogenics Corp, Subsidiaries 17

List Of Figures

List of Figures
Corcept Therapeutics Inc, Performance Chart (2013 - 2017) 24
Corcept Therapeutics Inc, Ratio Charts 26
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Corcept Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

Histogenics Corp (HSGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Histogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders. The companys product include neocart, an tissue implant produced using a patients own

USD 250View Report

Histogenics Corporation Strategic Analysis Review- Histogenics Corporation SWOT, Outlook, Operations and Financial Profile

Histogenics Corporation Company Profile provides strategic analysis of Histogenics Corporation Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth opportunities available

USD 200View Report

Histogenics Corporation Strategic Analysis Review- Histogenics Corporation SWOT, Outlook, Operations and Financial Profile

Histogenics Corporation Company Profile provides strategic analysis of Histogenics Corporation Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth opportunities available

USD 200View Report

Histogenics Corp (HSGX) - Medical Equipment - Deals and Alliances Profile

Histogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders. The companys product include neocart, an tissue implant produced using a patients own

USD 250View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :30
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube